Pfizer Canada's investment of $900,000 supports projects nationwide that help improve the lives and care of Canadians living with lung, colorectal, prostate or bladder cancer. World Cancer Day's 2026 ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsAndrew Guggenhime - President & CFOGrant Pickering ...

The BRAFTOVI combination regimen is the only approved targeted regimen for first-line BRAF-V600E mutant metastatic colorectal cancerPivotal results from the Phase 3 portion with mFOLFOX6 of the ...

For the 20 years Blonski took Depo-Provera, she thought it was safe. Her lawsuit claims that had she known of the dangers ...

As Chair of the Scientific Advisory Committee, Dr. Lewis-Hall will provide leadership in scientific, clinical, and regulatory governance across Helus' portfolio, advising on discovery opportunities, ...

The latest data point to improvements for many cancer types and a continued decline in overall cancer mortality.

BREAKWATER trial Cohort 3 analysis demonstrated statistically significant and clinically meaningful improvement in ...

Over the years, Oyeyinka has served in several high-level policy and academic roles, including as Senior Special Adviser on ...

By Stine Jacobsen and Louise Rasmussen COPENHAGEN, Feb 20 (Reuters) - Novo Nordisk will nominate drug industry veterans Jan ...

Dr. Paul Bunge begins his new book about COVID-19 by inviting readers to join him on a journey — one he knows will be uncomfortable, perhaps even full of disagreements. Bunge, a former U.S.

"Devyn brings a rare combination of scientific depth, operational leadership, and strategic perspective," said Nazli Azimi, Ph.D., Chief Executive Officer of Therna. "His experience across genetic ...